10-Q: Q3 2024 Earnings Report
8-K: Interpace Biosciences Announces Record Third Quarter 2024 Financial and Business Results
10-Q: Q2 2024 Earnings Report
8-K: Interpace Biosciences Announces Record Second Quarter 2024 Financial and Business Results
8-K: Interpace Biosciences Announces First Quarter 2024 Financial and Business Results
10-Q: Q1 2024 Earnings Report
10-K/A: Annual report (Amendment)
Interpace Biosciences Inc | 10-K: FY2023 Annual Report
Interpace Biosciences Inc | 8-K: Interpace Biosciences Announces Preliminary Full-year and Fourth Quarter 2023 Financial and Business Results
Interpace Biosciences Inc | 8-K: Interpace Biosciences Announces Record Third Quarter 2023 Financial and Business Results
Interpace Biosciences Inc | 10-Q: Quarterly report
Interpace Biosciences Inc | 8-K: Interpace Biosciences Announces Record Second Quarter 2023 Financial and Business Results
Interpace Biosciences Inc | 10-Q: Q2 2023 Earnings Report
Interpace Biosciences Inc | 8-K: Interpace Biosciences Announces Record First Quarter 2023 Financial and Business Results
Interpace Biosciences Inc | 10-Q: Q1 2023 Earnings Report
Interpace Biosciences Inc | 10-K/A: Annual report (Amendment)
Interpace Biosciences Inc | 8-K: Interpace Biosciences Announces Full Year and Fourth Quarter 2022 Financial and Business Results
Interpace Biosciences Inc | 10-K: FY2022 Annual Report
Interpace Biosciences Inc | 10-Q: Q3 2022 Earnings Report
Interpace Biosciences Inc | 8-K: Interpace Biosciences Announces Third Quarter 2022 Financial and Business Results Sale of Pharma Significantly Improves Liquidity Resulting in Removal of Going Concern